Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) FCF Margin (2022 - 2025)

Historic FCF Margin for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to 428.56%.

  • Cannabis Bioscience International Holdings' FCF Margin fell 4115600.0% to 428.56% in Q3 2025 from the same period last year, while for Aug 2025 it was 271.63%, marking a year-over-year decrease of 1490200.0%. This contributed to the annual value of 108.78% for FY2025, which is 838700.0% up from last year.
  • According to the latest figures from Q3 2025, Cannabis Bioscience International Holdings' FCF Margin is 428.56%, which was down 4115600.0% from 412.84% recorded in Q2 2025.
  • Over the past 5 years, Cannabis Bioscience International Holdings' FCF Margin peaked at 17.0% during Q3 2024, and registered a low of 1020.82% during Q4 2022.
  • For the 4-year period, Cannabis Bioscience International Holdings' FCF Margin averaged around 336.05%, with its median value being 369.8% (2023).
  • Per our database at Business Quant, Cannabis Bioscience International Holdings' FCF Margin soared by 6737500bps in 2023 and then plummeted by -5297000bps in 2025.
  • Quarter analysis of 4 years shows Cannabis Bioscience International Holdings' FCF Margin stood at 1020.82% in 2022, then surged by 66bps to 347.07% in 2023, then soared by 72bps to 97.09% in 2024, then plummeted by -341bps to 428.56% in 2025.
  • Its FCF Margin was 428.56% in Q3 2025, compared to 412.84% in Q2 2025 and 554.63% in Q1 2025.